Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE3

Conditions

Small-cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shanghai Chest Hospital, Shanghai, Shanghai Municipality, China

Study leads

Jason Wu
Study Chair
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Non-Small-Cell Lung Cancer · Metastatic Non-Small-Cell Lung Cancer · Advanced Non-Small-Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE3

Los Angeles, United States · Sacramento, United States

Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer

Non-Small-Cell Lung Cancer (NSCLC) · Brain Metastasis

Abroad (travel likely)RecruitingPHASE2, PHASE3

Taoyuan, Taiwan

Lung Cancer Biomarkers and Screening

Lung Cancer

Abroad (travel likely)Recruiting

New York, United States

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

Non-small Cell Lung Cancer Stage III · Non-small Cell Lung Cancer Stage IV · Non-small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Cleveland, United States